NCT06017687 Data Collection and Evaluation of OptiBP Under Investigational Use
| NCT ID | NCT06017687 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Biospectal |
| Condition | General Population |
| Study Type | INTERVENTIONAL |
| Enrollment | 500,000 participants |
| Start Date | 2023-09-28 |
| Primary Completion | 2024-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 500,000 participants in total. It began in 2023-09-28 with a primary completion date of 2024-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to collect data to develop and evaluate the use of state-of-the-art machine learning approaches within a mobile phone application for the estimation of blood pressure.
Eligibility Criteria
Inclusion Criteria: 1. Be at least 18 years old (at least 19 years old in Alabama and Nebraska, at least 21 years old in Puerto Rico); 2. Live in the United States of America 3. Have an Android smartphone 4. Have access to an arm-worn blood pressure monitor (cuff) 5. Have access to the Google Play store to download the OptiBP study app on their phone 6. Be comfortable communicating in written and spoken English 7. Be willing and able to provide informed consent to participate in the study Exclusion Criteria: 1. Known contact dermatitis to nickel/chromium 2. Lesion or deficiency on hand, preventing placing a finger on the smartphone camera 3. Known dysrhythmia like bigeminy, trigeminy, isolated VPB, atrial fibrillation
Contact & Investigator
Frederic Frappereau
PRINCIPAL INVESTIGATOR
Biospectal
Frequently Asked Questions
Who can join the NCT06017687 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying General Population. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06017687 currently recruiting?
Yes, NCT06017687 is actively recruiting participants. Contact the research team at study@biospectal.com for enrollment information.
Where is the NCT06017687 trial being conducted?
This trial is being conducted at Truckee, United States.
Who is sponsoring the NCT06017687 clinical trial?
NCT06017687 is sponsored by Biospectal. The principal investigator is Frederic Frappereau at Biospectal. The trial plans to enroll 500,000 participants.